abrdn Life Sciences Investors Overview

abrdn Life Sciences Investors Profit Margin

Profitability ratio analysis for HQL.

Quarterly Profit Margin

135.93%

↑ 152.37% YoY

As of Mar 2026

Annual Profit Margin (TTM)

136.37%

↓ 26.46% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin